MRCOG - Part 2 > Fibroids > Flashcards

Fibroids Flashcards

(81 cards)

Study These Flashcards
1
Q

What are fibroids

A

Benign tumours arising from the myometrium of the uterus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of fibroids

A
  1. Subserosal
  2. Intramural
  3. Submucosal
  4. Pedunculated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is submucosal fibroid

A

develop near the outer serosal surface of the uterus and extend into the peritoneal cavity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

symptoms of Subserosal fibroids

A

Asymptomatic; may cause pressure symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Intramural fibroids

A

fibroids develop within the myometrium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

symptoms of intramural fibroids

A

May cause HMB, dysmenorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Symptoms of submucosal fibroids

A

May cause HMB, pain, and subfertility.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are submucosal fibroid

A

develop near the endometrial surface of the uterus and extend into the uterine cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are pedunculate fibroids

A

attached to the myometrium by a pedicle. May cause torsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

History (symptoms and signs) of Fibroids

A
  • Symptoms depend on the size, number, and location of the fibroids
  • Heavy & prolonged bleeding (most common)
  • Abdominal swelling, pelvic or abdominal pain or discomfort.
  • Dyspareunia.
  • Pressure symptoms – constipation or urinary symptoms such as
    frequency or difficulty in voiding.
  • Acute, severe abdominal or pelvic pain following torsion of a pedunculated fibroid or ‘red degeneration’.
  • Subfertility, miscarriage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Abdominal examination in case of fibroids

A

mass arising from the pelvis, smooth/multi-nodular, firm, mobile from side-to-side.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pelvic examination in case of fibroids

A
  • mass arising out of the pelvis, with an irregular knobbly shape, a firm or hard consistency, and can be moved slightly from side-to- side.
  • Any movement of the abdominal mass moves the cervix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prevalence of fibroids

A

Prevalence increases progressively from puberty until the menopause.
- 40–60% of women have fibroids by 35 years of age.
- which is increased to 70–80% by 49 years of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Do fibroids resolve with age

A

Usually shrink after menopause as they are promoted and maintained by oestrogen and progestogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prevalence of fibroids is higher in which groups?

A
  • Black women
  • Women with early onset of puberty.
  • Obese women – probably due to higher oestrogen levels.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gynecological risks due to fibroids

A
  • HBM – anaemia, affects QOL.
  • Compression of ureters by large fibroids - hydronephrosis.
  • Torsion of pedunculated fibroid – acute pain.
  • Leiomyosarcoma – minimal risk.
  • Fertility issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pregnancy complications due to fibroids

A
  • 1st and 2nd trimester miscarriage.
  • Higher rates of CS
  • Preterm delivery.
  • Malpresentation, mechanical complications in labour.
  • PPH.
  • Acute pain requiring hospital admission (5–6%) – red degeneration of
    fibroid owing to avascular necrosis (when rapid growth of a fibroid, promoted by high levels of sex hormones, outgrows its blood supply).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

DD of fibroids

A
  • Adenomyosis: difficult to distinguish from fibroids may be associated with it
  • Pregnancy
  • Benign causes of a pelvic mass: benign ovarian mass –
    hemorrhagic cyst, dermoid cyst, or endometrioma.
  • Malignant causes of a pelvic mass: ovarian cancer,
    endometrial cancer, leiomyosarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Investigations for diagnosis of Fibroids

A
  1. USS
  2. Saline or contrast sonographyL improves assessment of SM fibroids
  3. 3D USS
  4. MRI: superior to conventional US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

when to refer asymptomatic fibroids to 2ry care

A
  • Fibroids are palpable abdominally.
  • Intra-cavity fibroids.
  • Uterine length on USS>12 cm.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Do we advise hysterectomy for asymptomatic fibroids

A

Do not advise hysterectomy for asymptomatic fibroids solely to improve detection of adnexal masses, to prevent impairment of renal function, or to rule out malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Medical management of symptomatic fibroids

A
  1. NSAIDs
  2. Contraceptive steroids (COCs)
  3. LNG-IUS
  4. Anti-Progesterone agents (mifepristone)
  5. Aromatase Inhibitors
  6. GNRH agonists
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How do fibroids cause HMB ?

A
  • Mass effect causing increased surface area
  • Interferes with uterine contractility
  • Increased vascularity
  • Altered prostaglandin production
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

FIGO classification for fibroids ?

A

submucosal
0 submucosal
1- <50% intramural
2 ->50% intra mural

OTHERs
3- contacts endometrium but is intramural
4-intramural
5-subserosal but> 50% intra mural
6- subserosal <50% intramural
7-oendunculated

STEPW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Routes for myomectomy ?
- Hysteroscopic - Abdominal - Open, Lap, Robotic * Hysteroscopic for submucosal - 0,1 * Rest - Abdominal route
26
(fibroids) When is the risk of malignancy higher ? and how to minimize risk of malignancy spreading
Postmenopausal Premenopausal - if solitary large lesion not responding to GnrH or ulipristal 1 in 2000 Avoid morcellation. If done - use bags for removal
27
Disadvantage of using Gnrh prior to myomectomy?
Loss of surgical planes
28
Which is better in ttt of fibroids Total or subtotal hysterectomy?
Total obviates the need for further surgery as it removes the cervix Subtotal associated with lesser morbidity and faster recovery So let the patient decide
29
How do we decide the route of hysterectomy in ttt of fibroids
Abdominal preferred if no prolapse or associated pelvic pathology - adnexal mass, adhesions, endometriosis Vaginal - preferred in presence of prolapse In Abdominal - Lap preferred
30
Overall complication rate of hysterectomy?
4%
31
Hysterectomy accounts for what portion of genitourinary tract injury ?
75% 1-2% is the rate for all gynaecological procedures combined Of these, 75% due to hysterectomy
32
Injury to GI tract during hysterectomy?
0.1-1%
33
Vaginal cuff dehiscence most common after which procedure?
TLH
34
Urinary tract injury more common after which procedure?
TLH
35
Out of ablation and hysterectomy More likely to undergo future gynecological surgery in terms of repeat procedure? More likely to have surgery for incontinence, prolapse ?
Ablation - more common on the 1st 2 years Hysterectomy- more likely to undergo surgery for prolapse, Incontinence
36
Mode of action of anti progesterone
Mifepristone acts at the level of the progesterone receptors, found in high concentration in fibroids.
37
effect of anti-progesterone on fibroids
-Reduction in fibroid volume of 26–74% (comparable to GnRHa, slower rate of recurrent growth after cessation of mifepristone treatment). - amenorrhoea rates up to 90% - stable bone mineral density.
38
SE of Anti-progesterone
* endometrial hyperplasia without atypia (14–28%) * transient elevations in transaminase levels (4%) requiring LFT monitoring.
39
Mode of action of Aromatase inhibitors in ttt of fibroids
Aromatase inhibitors block ovarian and peripheral oestrogen production and decrease oestradiol levels. Small studies showed reduction in leiomyoma size and symptoms.
40
efficacy of GNRHa in ttt fibroids
35–65% reduction in fibroid volume within 3 months.
41
Disadvantages of use of preoperative GNRHa
it may make the fibroids softer and the surgical planes less distinct, leading to difficulty in dissection.
42
Surgical management of fibroids
- hysterectomy - myomectomy (abd., laparoscopic, hysteroscopic) - UAE
43
Advantages of hysterectomy in ttt of fibroids
* Relieves symptoms * prevents recurrence * provides permanent contraception * allows treatment with oestrogen-only HRT.
44
Risks of Abdominal myomectomy
hysterectomy blood loss risk of transfusion adhesions.
45
Rate pf recurrence of fibroids after abd myomectomy
depends on the number of fibroids; single leiomyoma – 27% risk multiple leiomyomas – 59% risk. ** preoperative use of GnRH agonists affects recurrence risk.**
46
Advantages of laparoscopic myomectomy over abdominal
- less haemoglobin drop - reduced operative blood loss - quicker recovery, diminished postoperative pain - fewer overall complications but longer operation time.
47
Cautions during Patient selection to laparoscopic myomectomy
be cautious if: - fibroids > 5–8 cm - multiple fibroids - or presence of deep IM leiomyomas as it may be associated with increased operative time and blood loss.
48
Recurrence rate pf fibroids after laparoscopic myomectomy
- 12% at 1 year - up to 84% at 8 years.
49
Conversion rate of laparoscopic to abdominal myomectomy
11%
50
Rate of complication of laparoscopic myomectomy
8-11%
51
Indications for hysteroscopic myomectomy
abnormal uterine bleeding caused by SM fibroids.
52
Classification for hysteroscopic myomectomy
Classified based on the amount of leiomyoma within the uterine cavity: * Type 0 – completely intra-cavitary. * Type I – < 50% intramural. * Type II – > 50% intramural.
53
Rate of Successful removal at the initial hysteroscopy myomectomy
85–95%
54
Rate of subsequent surgery after hysteroscopic myomectomy
5–15% and most of these cases involve a second hysteroscopic procedure.
55
Complications of hysteroscopic myomectomy
Complication rate of 1–5% * fluid overload with secondary hyponatraemia * pulmonary oedema * cerebral oedema * intraoperative and postoperative bleeding * uterine perforation * gas embolism *infection.
56
How is UAE is done?
Femoral artery is cannulated and an embolic agent is injected into the uterine arteries to impair the blood supply to the uterus and fibroids. This has a differential effect on f ibroids (that have a higher blood supply than the surrounding myometrium).
57
Effect of UAE on fibroids
Fibroid shrinkage – 60% by the end of 6 months with further shrinkage up to one year.
58
Indications for UAE
* surgery is CI. * unwilling to have a blood transfusion. * previous unsuccessful surgery for fibroids.
59
Absolute CI for UAE in case of fibroids
* Current or recent infection of genital tract. * Patient refusing hysterectomy under any circumstances. * Doubtful diagnosis due to the clinical factors or inadequate imaging.
60
UAE has more benefits in ttt of large or small fibroids
the outcome for smaller fibroids is better than for larger fibroids with similar complication rates. Large fibroid is not a contraindication. However, volume reduction might not be sufficient to satisfy patient’s expectations.
61
Pre-requisites begore UAE
Do not give GnRHa within 2 months prior to the procedure
62
Which is better in diagnosing fibroids and adnemyosis MRI or USS
MRI is superior
63
Action of UAE on Fibroids in presence of adenomyosis
Less effective
64
Immediate complications of UAE
1. Groin Hematoma 2. Arterial thrombosis 3. Pseudo-aneurysm 4. Non-target embolization (presence of ovarian–uterine anastomoses can compromise the ovary.)
65
Early complications of UAE
* post-embolization syndrome: pain, nausea, fever, flu-like symptoms with raised inflammatory markers and white cell count. | frequent and self-limiting
66
Management of post-embolization syndrome
* Frequent and self-limiting. * Manage with analgesics and anti-inflammatory drugs. * Re-admission may be required in 3–5% of cases.
67
Late complications of UAE
* Vaginal discharge (self-limiting) – 20–30%. * Fibroid expulsion – 10%, more w/ SM * Sexual dysfunction – 12% * Infection (endometritis) – 0.5%. * Amenorrhoea (POI) – 1.5–7%, but the majority of these patients are > 45 years old (25% risk in this age group)
68
Precentage of further treatment of fibroids after UAE
1. repeat UAE 2. exploration of uterine cavity 3. myomectomy 4. hysterectomy * 25% if < 40 years * 10% if 40–50 years of ag
69
What kind of contraception to be used in case of fibroids
* W/o no uterine distortion: all methods can be used * W/ distortion: not IUD or IUS if can't be fitted easily | not clear if hormonal methods has any effect on size of fibroids
70
Clinical sign to Leiomyosarcoma
rapid growth in uterine size
71
Incidence of leiomysarcoma
rare 2-3/1000
72
Risk factors for sacrcomas
* Increasing age * a history of prior pelvic radiation * tamoxifen use * a rare genetic predisposition.
73
How to differentiate between sarcomas and other intrauterine lesions
MRI and Endometrial Biopsy
74
Do Fibroids do absolute subfertility?
no, many women can concieve w/o interventions
75
How can fbroids cause subfertility
1. mechanical effect due to cavity distortion with IM and SM fibroids 2. possible effect on uterine blood flow 3. impaired implantation with IM fibroids.
76
rate of fibroids presence in women w/ infertility
5–10% of women with infertility fibroids are the sole factor in 1–2.4% of women with infertility.
77
IVF outcome in women with fibroids
* SM/IM fibroids distorting the uterine cavity cause a 70% reduction in pregnancy * Removal of these fibroids restores the pregnancy rate to that of the control group.
78
Management of subfertility due to fiborids
* Try naturally for 2 years, unless the woman is ≥ 34 years * SM fibroids: hysteroscopic resection. * Myomectomy: consider for a woman with fibroids who has undergone unsuccessful IVF cycles despite appropriate ovarian response and good quality embryos. * UAE: has not effect on pregnancy outcome after IVF
79
# SBA What proportion of women using ulipristal acetate will develop Progesterone receptor modulator associated endometral changes PAEC?
* 60% * up to 2/3 of women using it * resolve after 6 months of discontinuation
80
# SBA Most common benign tumor in females
Uterine Leiomyoma prevelance= 30%
81
Recall Most common causes of postmenopausal bleeding
1 atrophic vaginitis 60-80% 2. Endometrial cancer 10% 3. Endometrial or cx polyp 2-12%
MRCOG - Part 2
flashcards
Decks in class (75)
# Cards
Brainscape helps you reach your goals faster, through stronger study habits.
© 2026 Bold Learning Solutions. Terms and Conditions